GlassScriptPhysician profile
David Melendez
NPI 1548229222
$8,354.33
in general payments reported to CMS, 2019-2025
45 companies · $76.10 in 2025
The $76.10 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,619 · 2020: $1,140 · 2021: $2,308 · 2022: $1,498 · 2023: $987 · 2024: $725 · 2025: $76.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,788.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,705.44 | 2019-2024 | |
| Boston Scientific Corporation | $593.76 | 2019 | |
| Organon LLC | $569.39 | 2021-2025 | Nexplanon, Nuvaring |
| Agile Therapeutics, INC. | $466.22 | 2021-2024 | Twirla |
| Mayne Pharma Commercial LLC | $433.73 | 2021-2024 | |
| Amgen INC. | $416.49 | 2019-2024 | Prolia, Evenity |
| Davol INC. | $402.43 | 2020-2021 | |
| Gynesonics, INC. | $394.42 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $307.73 | 2019-2024 | |
| Therapeuticsmd, INC. | $305.65 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $292.93 | 2021-2022 | |
| Avion Pharmaceuticals | $231.50 | 2019-2023 | Balcoltra |
| Astellas Pharma US INC | $188.06 | 2021-2024 | Myrbetriq, Veozah |
| Merck Sharp & Dohme LLC | $176.87 | 2019-2023 | Gardasil 9 |
| Pfizer INC. | $170.19 | 2019-2023 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $167.94 | 2020-2022 | |
| Hologic Sales and Service, LLC | $159.25 | 2020-2025 | Aptima, Thinprep 2000 Processor |
| Eisai INC. | $149.22 | 2020-2021 | |
| Exeltis, USA INC. | $137.48 | 2019-2021 | |
| Minerva Surgical, INC | $127.80 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $122.36 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $94.61 | 2019-2025 | Paragard T 380a, Endosee |
| Sage Therapeutics, LLC | $91.85 | 2021-2024 | |
| Mylan Pharmaceuticals INC. | $82.33 | 2021-2022 | |
| Roche Diagnostics Corporation | $81.40 | 2019-2020 | |
| Allergan, INC. | $72.77 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $41.95 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $39.53 | 2019-2021 | |
| Millicent US INC | $32.60 | 2020-2024 | Intrarosa |
| Myovant Sciences INC. | $31.44 | 2022 | |
| Scynexis, INC. | $25.78 | 2022 | |
| Medicem INC. | $23.53 | 2020 | |
| Spr Therapeutics, INC | $22.90 | 2023 | Sprint Pns System |
| Axonics, INC. | $21.99 | 2022 | |
| Cook Medical LLC | $21.21 | 2021 | |
| Alydia Health | $20.51 | 2021 | |
| Ascend Therapeutics US, LLC | $18.31 | 2023 | |
| Medtronic, INC. | $15.81 | 2024 | Truclear |
| Covidien LP | $15.71 | 2020 | |
| Duchesnay USA Incorporated | $15.36 | 2019 | |
| Exact Sciences Corporation | $14.76 | 2023 | Cologuard Collection Kit |
| Mission Pharmacal Company | $14.13 | 2021 | |
| Kci USA, INC. | $13.66 | 2021 | |
| Baudax Bio INC. | $11.95 | 2021 | |
| Mallinckrodt Hospital Products INC. | $11.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Melendez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.